The in vitro antibacterial activity of the anthelmintic drug oxyclozanide against common small animal bacterial pathogens.

Matthew R Levinson Joseph M BlondeauWayne S RosenkrantzCurtis B Plowgian

Published in: Veterinary dermatology (2019)

Oxyclozanide demonstrated in-vitro antibacterial activity against meticillin-resistant S. pseudintermedius. Further studies are needed to evaluate the potential use of oxyclozanide as a topical bactericidal agent.

Keyphrases

silver nanoparticles
staphylococcus aureus
gram negative
case control
human health
adverse drug
drug induced
multidrug resistant
climate change